Radiation induced brachial plexopathy in Head and Neck cancer patients treated with Definitive Radiotherapy and correlation with disease characteristics and dosimetric parameters
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2020 - 2023
Project Lead
F Hadrian Noel Alexander
Authors
F Hadrian Noel Alexander, Nirmala Srikantia, Sandeep Muzumder, Avinash H Udayashankara, Mg John Sebastian, Deepu C Tom, R P Kathiressan, John Michael Raj
Project Status
completed
Project Type
Retrospective Cohort Study